BRIAN K SIEGEL

Allopathic & Osteopathic Physicians|Surgery|Surgical Critical Care SOMERVILLE, NJ NPI 1477555977

General Payments — all program years on this page

$5,678.83

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 69
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,113.32 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,113.3214

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $322.633
Shionogi Inc $227.262
La Jolla Pharmaceutical Company $133.742
Gilead Sciences, Inc. $124.991
Haemonetics Corporation $121.211
CSL Behring $117.201
PFIZER INC. $48.643
Mindray DS USA, Inc. $17.651

By program year

Program yearAmountRecords
2018 $108.456
2019 $1,780.7817
2020 $319.027
2021 $225.792
2022 $696.888
2023 $1,434.5915
2024 $1,113.3214

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104335194 AstraZeneca Pharmaceuticals LP $107.63 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104410723 AstraZeneca Pharmaceuticals LP $107.50 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105406130 AstraZeneca Pharmaceuticals LP $107.50 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131058928 PFIZER INC. $16.38 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131323886 PFIZER INC. $14.88 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131879951 PFIZER INC. $17.38 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133836474 Gilead Sciences, Inc. $124.99 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134663397 CSL Behring $117.20 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143868281 Haemonetics Corporation $121.21 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150672433 Mindray DS USA, Inc. $17.65 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154251186 La Jolla Pharmaceutical Company $119.22 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154251188 La Jolla Pharmaceutical Company $14.52 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154341312 Shionogi Inc $123.65 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154341340 Shionogi Inc $103.61 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.